Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
ATP(CTP):tRNA nucleotidyltransferase
-
-C-C-A pyrophosphorylase
-
-
-
-
ATP(CTP)-tRNA nucleotidyltransferase
-
-
-
-
ATP:tRNA adenylyltransferase
-
-
-
-
ATP:tRNA nucleotidyltransferase (CTP)
-
-
-
-
class 2 tRNA-nucleotidyltransferase
-
-
class II CCA-adding enzyme
-
-
CTP(ATP):tRNA nucleotidyltransferase
-
-
-
-
CTP:tRNA cytidylyltransferase
-
-
-
-
ribonucleic cytidylic cytidylic adenylic pyrophosphorylase
-
-
-
-
ribonucleic cytidylyltransferase
-
-
-
-
transfer ribonucleate adenyltransferase
-
-
-
-
transfer ribonucleate adenylyltransferase
-
-
-
-
transfer ribonucleate adenylyltransferase,
-
-
-
-
transfer ribonucleate cytidylyltransferase
-
-
-
-
transfer ribonucleate nucleotidyltransferase
-
-
-
-
transfer ribonucleic acid nucleotidyl transferase
-
-
-
-
transfer ribonucleic adenylyl (cytidylyl) transferase
-
-
-
-
transfer ribonucleic-terminal trinucleotide nucleotidyltransferase
-
-
-
-
transfer RNA adenylyltransferase
-
-
-
-
transfer-RNA nucleotidyltransferase
-
-
-
-
tRNA adenylyl(cytidylyl)transferase
-
-
-
-
tRNA adenylyltransferase
-
-
-
-
tRNA CCA-pyrophosphorylase
-
-
-
-
tRNA cytidylyltransferase
-
-
-
-
tRNA-nucleotidyltransferase
-
-
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
a tRNA precursor + 2 CTP + ATP
a tRNA with a 3' CCA end + 3 diphosphate
-
-
-
?
armless tRNA(Arg) precursor + 2 CTP
armless tRNA(Arg) with a 3' CC end + 2 diphosphate
poor substrate for wild-type
-
-
?
armless tRNA(Arg) precursor + 2 CTP + ATP
armless tRNA(Arg) with a 3' CCA end + 3 diphosphate
poor substrate for wild-type
-
-
?
armless tRNA(Ile) precursor + 2 CTP
armless tRNA(Ile) with a 3' CC end + 2 diphosphate
poor substrate for wild-type
-
-
?
armless tRNA(Ile) precursor + 2 CTP + ATP
armless tRNA(Ile) with a 3' CCA end + 3 diphosphate
poor substrate for wild-type
-
-
?
tRNA(Phe) precursor + 2 CTP
tRNA(Phe) with a 3' CC end + 2 diphosphate
-
-
-
?
tRNA(Phe) precursor + 2 CTP + ATP
tRNA(Phe) with a 3' CCA end + 3 diphosphate
-
-
-
?
yeast tRNAPhe + 2 CTP + ATP
yeast tRNAPhe with 3'-CCA end + 3 diphosphate
preparation of substrate lacking the CCA-terminus or ending with a partial CCA-end
-
-
?
a tRNA precursor + 2 CTP + ATP
a tRNA with a 3' CCA end + 3 diphosphate
a tRNA with a 3' CCA end + 3 diphosphate
a tRNA precursor + 2 CTP + ATP
additional information
?
-
a tRNA precursor + 2 CTP + ATP
a tRNA with a 3' CCA end + 3 diphosphate
-
-
-
-
r
a tRNA precursor + 2 CTP + ATP
a tRNA with a 3' CCA end + 3 diphosphate
-
substrate is synthetic DNA templates based on the sequence of Escherichia coli tRNAVal. Overall reaction, class II CCA-adding enzymes also perform the reverse reaction, mechanism, overview. The enzyme catalyzes diphosphorolysis slowly relative to the forward nucleotide addition and that it exhibits weak binding affinity to diphosphate relative to NTP
-
-
r
a tRNA with a 3' CCA end + 3 diphosphate
a tRNA precursor + 2 CTP + ATP
-
-
-
-
r
a tRNA with a 3' CCA end + 3 diphosphate
a tRNA precursor + 2 CTP + ATP
-
substrate is synthetic DNA templates based on the sequence of Escherichia coli tRNAVal. Overall reaction, class II CCA-adding enzymes also perform the reverse reaction, mechanism, overview. The enzyme catalyzes diphosphorolysis slowly relative to the forward nucleotide addition and that it exhibits weak binding affinity to diphosphate relative to NTP
-
-
r
additional information
?
-
the enzyme catalyses a unique template-independent but sequence-specific nucleotide polymerization reaction, active site structure and molecular mechanism, overview. Construction of a corkscrew model for CCA addition that includes a fixed active site and a traveling tRNA-binding region formed by flexible parts of the protein
-
-
?
additional information
?
-
-
the enzyme catalyses a unique template-independent but sequence-specific nucleotide polymerization reaction, active site structure and molecular mechanism, overview. Construction of a corkscrew model for CCA addition that includes a fixed active site and a traveling tRNA-binding region formed by flexible parts of the protein
-
-
?
additional information
?
-
-
CCA-adding enzymes recognize tRNA and tRNA-like structures as substrates, select and discriminate the correct nucleotides CTP and ATP against UTP and GTP, and, after incorporation of two C residues, the nucleotide specificity has to switch towards ATP without the help of a nucleic acid template. The enzymes have to stop polymerization exactly after three positions and recognize partial CCA-ends and add only the missing residues for completion, instead of stubbornly adding CCA-ends to their substrates, overview
-
-
?
additional information
?
-
-
the specific enzyme incorporates only a highly restricted number of nucleotides in a tRNA primer and then stops polymerization at a high efficiency and accuracy. It selects exclusively CTP and ATP for incorporation and discriminates strongly against the other two nucleotide triphosphates. It does not require a nucleic acid template for directing order and nature of nucleotides to be inserted and is highly selective for tRNA-like structures as a polymerization substrate. The enzyme fulfills both functions in maintenance/repair as well as de novo polymerization
-
-
?
additional information
?
-
-
class 2 enzymes select the nucleotides to be incorporated by a true amino acid template that consists of the three highly conserved residues glutamic acid, aspartic acid and arginine (EDxxR). The arginine residue forms hydrogen bonds with ATP (1 bond) and CTP (2 bonds), assisted by aspartate that contributes one hydrogen bond
-
-
?
additional information
?
-
-
only class II CCA enzymes catalyze diphosphorolysis, the reaction can initiate from all three CCA positions and proceed processively until the removal of nucleotide C74. Diphosphorolysis enables class II enzymes to efficiently remove an incorrect A75 nucleotide from the 3' end, at a rate much faster than the rate of A75 incorporation, suggesting the ability to perform a previously unexpected quality control mechanism for CCA synthesis. No activity with non-tRNA substrate BMVTLSTyr or U2 snRNA. The enzyme shows a robust activity with tRNA-A75, degrading it down to tRNA-A73 (by 50%) while showing a minor activity with tRNA-C76 (less than 5% substrate conversion) and no activity with tRNA-A74. The incorrect A75 is more readily removed than it is synthesized, suggesting a quality control mechanism that can improve the overall accuracy of CCA synthesis
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
a tRNA precursor + 2 CTP + ATP
a tRNA with a 3' CCA end + 3 diphosphate
-
-
-
-
r
a tRNA with a 3' CCA end + 3 diphosphate
a tRNA precursor + 2 CTP + ATP
-
-
-
-
r
additional information
?
-
additional information
?
-
the enzyme catalyses a unique template-independent but sequence-specific nucleotide polymerization reaction, active site structure and molecular mechanism, overview. Construction of a corkscrew model for CCA addition that includes a fixed active site and a traveling tRNA-binding region formed by flexible parts of the protein
-
-
?
additional information
?
-
-
the enzyme catalyses a unique template-independent but sequence-specific nucleotide polymerization reaction, active site structure and molecular mechanism, overview. Construction of a corkscrew model for CCA addition that includes a fixed active site and a traveling tRNA-binding region formed by flexible parts of the protein
-
-
?
additional information
?
-
-
CCA-adding enzymes recognize tRNA and tRNA-like structures as substrates, select and discriminate the correct nucleotides CTP and ATP against UTP and GTP, and, after incorporation of two C residues, the nucleotide specificity has to switch towards ATP without the help of a nucleic acid template. The enzymes have to stop polymerization exactly after three positions and recognize partial CCA-ends and add only the missing residues for completion, instead of stubbornly adding CCA-ends to their substrates, overview
-
-
?
additional information
?
-
-
the specific enzyme incorporates only a highly restricted number of nucleotides in a tRNA primer and then stops polymerization at a high efficiency and accuracy. It selects exclusively CTP and ATP for incorporation and discriminates strongly against the other two nucleotide triphosphates. It does not require a nucleic acid template for directing order and nature of nucleotides to be inserted and is highly selective for tRNA-like structures as a polymerization substrate. The enzyme fulfills both functions in maintenance/repair as well as de novo polymerization
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Agammaglobulinemia
A Novel Homozygous TRNT1 Mutation in a Child With an Early Diagnosis of Common Variable Immunodeficiency Leading to Mild Hypogammaglobulinemia and Hemolytic Anemia.
Agammaglobulinemia
Novel biallelic TRNT1 mutations resulting in sideroblastic anemia, combined B and T cell defects, hypogammaglobulinemia, recurrent infections, hypertrophic cardiomyopathy and developmental delay.
Anemia
A Novel Homozygous TRNT1 Mutation in a Child With an Early Diagnosis of Common Variable Immunodeficiency Leading to Mild Hypogammaglobulinemia and Hemolytic Anemia.
Anemia
Genotype/phenotype correlations of childhood-onset congenital sideroblastic anaemia in a European cohort.
Anemia
Hypomorphic mutations in TRNT1 cause retinitis pigmentosa with erythrocytic microcytosis.
Anemia
Impaired activity of CCA-adding enzyme TRNT1 impacts OXPHOS complexes and cellular respiration in SIFD patient-derived fibroblasts.
Anemia, Hemolytic
A Novel Homozygous TRNT1 Mutation in a Child With an Early Diagnosis of Common Variable Immunodeficiency Leading to Mild Hypogammaglobulinemia and Hemolytic Anemia.
Anemia, Sideroblastic
A phenotypic expansion of TRNT1 associated sideroblastic anemia with immunodeficiency, fevers, and developmental delay.
Anemia, Sideroblastic
Atypical SIFD with novel TRNT1 mutations: a case study on the pathogenesis of B-cell deficiency.
Anemia, Sideroblastic
Biallelic TRNT1 variants in a child with B cell immunodeficiency, periodic fever and developmental delay without sideroblastic anemia (SIFD variant).
Anemia, Sideroblastic
Diseases Associated with Defects in tRNA CCA Addition.
Anemia, Sideroblastic
Expanding the Phenotype of TRNT1-Related Immunodeficiency to Include Childhood Cataract and Inner Retinal Dysfunction.
Anemia, Sideroblastic
Hypomorphic mutations in TRNT1 cause retinitis pigmentosa with erythrocytic microcytosis.
Anemia, Sideroblastic
Impaired activity of CCA-adding enzyme TRNT1 impacts OXPHOS complexes and cellular respiration in SIFD patient-derived fibroblasts.
Anemia, Sideroblastic
In vitro studies of disease-linked variants of human tRNA nucleotidyltransferase reveal decreased thermal stability and altered catalytic activity.
Anemia, Sideroblastic
Mutations in TRNT1 cause congenital sideroblastic anemia with immunodeficiency, fevers, and developmental delay (SIFD).
Anemia, Sideroblastic
Neutrophilic dermatosis: a new skin manifestation and novel pathogenic variant in a rare autoinflammatory disease.
Anemia, Sideroblastic
Novel biallelic TRNT1 mutations resulting in sideroblastic anemia, combined B and T cell defects, hypogammaglobulinemia, recurrent infections, hypertrophic cardiomyopathy and developmental delay.
Anemia, Sideroblastic
SIFD as a novel cause of severe fetal hydrops and neonatal anaemia with iron loading and marked extramedullary haemopoiesis.
Anemia, Sideroblastic
Two cases of sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD) syndrome in Chinese Han children caused by novel compound heterozygous variants of the TRNT1 gene.
Brain Diseases
Contribution of nuclear and mitochondrial gene mutations in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome.
Breast Neoplasms
Exploration of CCA-added RNAs revealed the expression of mitochondrial non-coding RNAs regulated by CCA-adding enzyme.
Cardiomyopathies
Atypical SIFD with novel TRNT1 mutations: a case study on the pathogenesis of B-cell deficiency.
Cardiomyopathies
Contribution of nuclear and mitochondrial gene mutations in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome.
Cardiomyopathy, Hypertrophic
Novel biallelic TRNT1 mutations resulting in sideroblastic anemia, combined B and T cell defects, hypogammaglobulinemia, recurrent infections, hypertrophic cardiomyopathy and developmental delay.
Cataract
Atypical SIFD with novel TRNT1 mutations: a case study on the pathogenesis of B-cell deficiency.
Cataract
Expanding the Phenotype of TRNT1-Related Immunodeficiency to Include Childhood Cataract and Inner Retinal Dysfunction.
cca trna nucleotidyltransferase deficiency
Atypical SIFD with novel TRNT1 mutations: a case study on the pathogenesis of B-cell deficiency.
cca trna nucleotidyltransferase deficiency
TRNT1 deficiency: clinical, biochemical and molecular genetic features.
Common Variable Immunodeficiency
A Novel Homozygous TRNT1 Mutation in a Child With an Early Diagnosis of Common Variable Immunodeficiency Leading to Mild Hypogammaglobulinemia and Hemolytic Anemia.
Epilepsy
Contribution of nuclear and mitochondrial gene mutations in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome.
Hearing Loss, Sensorineural
Contribution of nuclear and mitochondrial gene mutations in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome.
Infections
Novel biallelic TRNT1 mutations resulting in sideroblastic anemia, combined B and T cell defects, hypogammaglobulinemia, recurrent infections, hypertrophic cardiomyopathy and developmental delay.
Iron Overload
Genotype/phenotype correlations of childhood-onset congenital sideroblastic anaemia in a European cohort.
Metabolic Diseases
TRNT1 deficiency: clinical, biochemical and molecular genetic features.
Mitochondrial Diseases
Contribution of nuclear and mitochondrial gene mutations in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome.
Neoplasm Metastasis
[Spinal cord metastasis of anaplastic oligodendroglioma of the brain without recurrence of primary tumor. Ccase report and literature review].
Neoplasms
Inhibition of transfer ribonucleic acid nucleotidyl transferase (EC 2.7.7.25) from Ehrlich tumor cells by proflavine sulfate and ethidium bromide.
Neoplasms
[Spinal cord metastasis of anaplastic oligodendroglioma of the brain without recurrence of primary tumor. Ccase report and literature review].
Obesity
Obesity-insulin targeted genes in the 3p26-25 region in human studies and LG/J and SM/J mice.
Obesity, Abdominal
Obesity-insulin targeted genes in the 3p26-25 region in human studies and LG/J and SM/J mice.
Oligodendroglioma
[Spinal cord metastasis of anaplastic oligodendroglioma of the brain without recurrence of primary tumor. Ccase report and literature review].
Retinal Dystrophies
Expanding the Phenotype of TRNT1-Related Immunodeficiency to Include Childhood Cataract and Inner Retinal Dysfunction.
Retinitis Pigmentosa
Atypical SIFD with novel TRNT1 mutations: a case study on the pathogenesis of B-cell deficiency.
Retinitis Pigmentosa
Diseases Associated with Defects in tRNA CCA Addition.
Retinitis Pigmentosa
Hypomorphic mutations in TRNT1 cause retinitis pigmentosa with erythrocytic microcytosis.
Retinitis Pigmentosa
In vitro studies of disease-linked variants of human tRNA nucleotidyltransferase reveal decreased thermal stability and altered catalytic activity.
Retinitis Pigmentosa
TRNT1 deficiency: clinical, biochemical and molecular genetic features.
Seizures
Contribution of nuclear and mitochondrial gene mutations in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome.
Thrombocytosis
Genotype/phenotype correlations of childhood-onset congenital sideroblastic anaemia in a European cohort.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.008 - 0.119
a tRNA precursor
-
0.0013 - 0.00477
armless tRNA(Arg) precursor
-
0.002 - 0.00558
armless tRNA(Ile) precursor
-
0.00412 - 0.00428
tRNA(Phe) precursor
-
0.008
a tRNA precursor
mutant D139A, pH not specified in the publication, temperature not specified in the publication
-
0.119
a tRNA precursor
wild-type, pH not specified in the publication, temperature not specified in the publication
-
0.0013
armless tRNA(Arg) precursor
addition of 2C, pH 7.6, 20°C
-
0.00477
armless tRNA(Arg) precursor
addition of 2C + A, pH 7.6, 20°C
-
0.002
armless tRNA(Ile) precursor
addition of 2C + A, pH 7.6, 20°C
-
0.00558
armless tRNA(Ile) precursor
addition of 2C, pH 7.6, 20°C
-
0.00412
tRNA(Phe) precursor
addition of 2C, pH 7.6, 20°C
-
0.00428
tRNA(Phe) precursor
addition of 2C + A, pH 7.6, 20°C
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.09 - 0.11
a tRNA precursor
-
0.003 - 0.041
armless tRNA(Arg) precursor
-
0.006 - 0.165
armless tRNA(Ile) precursor
-
0.091 - 0.214
tRNA(Phe) precursor
-
0.09
a tRNA precursor
wild-type, pH not specified in the publication, temperature not specified in the publication
-
0.11
a tRNA precursor
mutant D139A, pH not specified in the publication, temperature not specified in the publication
-
0.003
armless tRNA(Arg) precursor
addition of 2C + A, pH 7.6, 20°C
-
0.041
armless tRNA(Arg) precursor
addition of 2C, pH 7.6, 20°C
-
0.006
armless tRNA(Ile) precursor
addition of 2C + A, pH 7.6, 20°C
-
0.165
armless tRNA(Ile) precursor
addition of 2C, pH 7.6, 20°C
-
0.091
tRNA(Phe) precursor
addition of 2C + A, pH 7.6, 20°C
-
0.214
tRNA(Phe) precursor
addition of 2C, pH 7.6, 20°C
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
physiological function
all tRNA molecules carry the invariant sequence CCA at their 3'-terminus for amino acid attachment. The post-transcriptional addition of CCA is carried out by ATP(CTP):tRNA nucleotidyltransferase, also called CCase. This enzyme catalyses a unique template-independent but sequence-specific nucleotide polymerization reaction
physiological function
conserved motif C in CCA-adding enzyme forms a flexible spring element modulating the relative orientation of the enzyme's head and body domains to accommodate the growing 3'-end of the tRNA. These conformational transitions initiate the rearranging of the templating amino acids to switch the specificity of the nucleotide binding pocket from CTP to ATP during CCA-synthesis
physiological function
introduction of a beta-turn element of the catalytic core into the human enzyme confers full CCA-adding activity on armless tRNAs. This region, identified to position the 3'-end of the tRNA primer in the catalytic core, dramatically increases the enzyme's substrate affinity. Conventional tRNA substrates bind to the enzyme by interactions with the T-arm, this is not possible in the case of armless tRNAs of the Romanomermis culicivorax mitochondrion
evolution
-
a class II CCA-adding enzyme. Compared to class I, class II CCA-adding enzymes show a much higher evolutionary conservation of individual catalytic core motifs. Evolution of class I and class II CCA-adding enzymes as well as poly(A) polymerases, overview
evolution
-
diphosphorolysis of class II enzymes establishes a fundamental difference from class I enzymes, and it is achieved only with the tRNA structure and with specific divalent metal ions
evolution
-
with a possible origin of ancient telomerase-like activity, the CCA-adding enzymes obviously emerged twice during evolution, leading to structurally different, but functionally identical enzymes. While the enzyme class 1 is exclusively found in archaea, class 2 tRNA-nucleotidyltransferases are present in eukaryotes and bacteria. In class 2 enzymes, only the head domain carries a beta sheet and forms the nucleotidyltransferase core, while neck, body and tail consist exclusively of alpha helices, giving the enzyme a hook- or seahorse-like overall structure. The chemical mechanism underlying the polymerization appears conserved in all polymerases across the three kingdoms of life
malfunction
-
CCA ends with misincorporated nucleotides are only rarely detected. Only under rather artificial in vitro conditions, e.g. in the presence of Mn2+ ions instead of Mg2+ or deviating NTP concentrations, incorporation of CCC as well as poly(C) tails can be observed
malfunction
-
mutations around the active site of the Sulfolobus shibatae enzyme interfere with CCA-addition, but have only a minor affect on tRNA binding
physiological function
-
CCA enzymes catalyze stepwise CCA addition to the tRNA 3' end at positions 74-76 as an obligatory sequence for tRNA activity in the cell. Only class II CCA enzymes catalyze pyrophosphorolysis, the reaction can initiate from all three CCA positions and proceed processively until the removal of nucleotide C74. Diphosphorolysis enables class II enzymes to efficiently remove an incorrect A75 nucleotide from the 3' end, at a rate much faster than the rate of A75 incorporation, suggesting the ability to perform a previously unexpected quality control mechanism for CCA synthesis
physiological function
-
CCA-adding enzymes represent vital components of the cell's tRNA maturation and maintenance system. The CCA end, added to the tRNA by the CCA tRNA nucleotidyltransferase, is the site of aminoacylation, and aminoacyl tRNA synthetases fuse the individual amino acids to the ribose moiety of the terminal A residue. Secondly, the CCA terminus is required for the correct positioning of the aminoacyl-tRNA in the ribosome's A- and P-site in order to guarantee an efficient peptidyl transfer reaction. The CCA-adding enzyme represents an essential activity in the majority of organisms
physiological function
-
tRNA-nucleotidyltransferases are RNA polymerases responsible for the synthesis of the nucleotide triplet CCA at the 3'-terminus of tRNAs. As this CCA end represents an essential functional element for aminoacylation and translation, the CCA-adding enzymes are of vital importance in all organisms. The enzyme fulfills both functions in maintenance/repair as well as de novo polymerization
physiological function
-
identification of candidate non-tRNA substrates of CCA-adding enzyme, i.e. fourteen CCA-RNAs that only contain CCA as non-genomic sequences, and eleven NCCA-RNAs that contain CCA and other nucleotides as non-genomic sequences. All (N)CCA-RNAs are derived from the mitochondrial genome and are localized in mitochondria. Knockdown of CCA-adding enzyme severely reduces the expression levels of (N)CCA-RNAs
additional information
-
in class 2 enzymes, only the head domain carries a beta-sheet and forms the nucleotidyltransferase core, while neck, body and tail consist exclusively of alpha helices, giving the enzyme a hook- or seahorse-like overall structure, structure-function relationship, overview
additional information
-
structure-function relationship, overview. The active site is located in the N-terminal part of the enzyme and consists of five elements that are involved in metal ion binding, catalysis, ribose recognition, nucleotide selection, and templating. Motif A is located in the head domain and includes the general signature motif of all nucleotidyltransferases with the two metal-binding carboxylates DxD that are involved in catalysis and binding of the triphosphate moiety of the incoming nucleotides. The head domain carries motif B, where highly conserved residues play a critical role in discriminating between NTPs and dNTPs. The neck domain contains motif D, a single nucleotide-binding pocket that is specific for binding of CTP and ATP. Head and neck domain form a cleft that binds the incoming nucleotide as well as the 3'-end of the tRNA primer. The body and tail domains at the enzyme's C-terminus recognize the top-half region of the tRNA primer. The CCA-enzyme does not move along the tRNA during synthesis but remains at a fixed position
additional information
-
the CCA enzymes are unusual RNA polymerases, which catalyze CCA addition to positions 74-76 at the tRNA 3' end without using a nucleic acid template, reaction mechanism of CCA addition and reverse phosphorolysis reaction, overview
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
D139A
mutant shows a strong reduction in the addition of the terminal A position
G143A
similar to wild-type, mutant catalyzes the addition of the complete CCA sequence
L166S
and T154I, compound heterozygous mutation identified in a patient with sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay
R153A
similar to wild-type, mutant catalyzes the addition of the complete CCA sequence
R190I
homozygous mutation identified in a patient with sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay
T154I
and L166S, compound heterozygous mutation identified in a patient with sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay
additional information
replacement of residues 100117 in the human enzyme by the corresponding part of the Escherichia coli enzyme, positions 6687, leading to the chimera HEH with human enzyme N-terminus, Escherichia coli flexible loop, human enzyme C-terminus. Replacement of the region in the Escherichia coli enzyme by the human loop element, representing the reciprocal experiment, chimera EHE. Whereas the wild-type enzymes incorporate the complete CCA sequence, the chimeric enzymes EHE, HEH show a reduced activity and add only 2 C residues to the tRNA substrate. The chimeras EHE, HEH show a 45- to 145fold reduced kcat for A-incorporation. The corresponding KM values are consistent with the KM values of the loop donor enzymes
additional information
-
replacement of the highly conserved residues glutamic acid, aspartic acid and arginine o f the EDxxR motif aabolishes nucleotide specificity of the enzyme
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Augustin, M.A.; Reichert, A.S.; Betat, H.; Huber, R.; Morl, M.; Steegborn, C.
Crystal structure of the human CCA-adding enzyme: insights into template-independent polymerization
J. Mol. Biol.
328
985-994
2003
Homo sapiens (Q96Q11), Homo sapiens
brenda
Hoffmeier, A.; Betat, H.; Bluschke, A.; Gunther, R.; Junghanns, S.; Hofmann, H.J.; Morl, M.
Unusual evolution of a catalytic core element in CCA-adding enzymes
Nucleic Acids Res.
38
4436-4447
2010
Geobacillus stearothermophilus, Escherichia coli, Homo sapiens (Q96Q11)
brenda
Mrl, M.; Betat, H.; Rammelt, C.
TRNA nucleotidyltransferases: ancient catalysts with an unusual mechanism of polymerization
Cell. Mol. Life Sci.
67
1447-1463
2010
Archaeoglobus fulgidus, Escherichia coli, Geobacillus stearothermophilus, Homo sapiens, Saccharolobus shibatae, Thermotoga maritima, Thermus thermophilus
brenda
Vrtler, S.; Mrl, M.
tRNA-nucleotidyltransferases: Highly unusual RNA polymerases with vital functions
FEBS Lett.
584
297-302
2010
Aquifex aeolicus, Archaea, Caldanaerobacter subterraneus subsp. tengcongensis, Deinococcus radiodurans, Escherichia coli, Halalkalibacterium halodurans, Homo sapiens, Thermus thermophilus
brenda
Igarashi, T.; Liu, C.; Morinaga, H.; Kim, S.; Hou, Y.
Pyrophosphorolysis of CCA addition: implication for fidelity
J. Mol. Biol.
414
28-43
2011
Archaeoglobus fulgidus, Escherichia coli, Homo sapiens
brenda
Sasarman, F.; Thiffault, I.; Weraarpachai, W.; Salomon, S.; Maftei, C.; Gauthier, J.; Ellazam, B.; Webb, N.; Antonicka, H.; Janer, A.; Brunel-Guitton, C.; Elpeleg, O.; Mitchell, G.; Shoubridge, E.A.
The 3 addition of CCA to mitochondrial tRNASer(AGY) is specifically impaired in patients with mutations in the tRNA nucleotidyl transferase TRNT1
Hum. Mol. Genet.
24
2841-2847
2015
Homo sapiens (Q96Q11), Homo sapiens
brenda
Liwak-Muir, U.; Mamady, H.; Naas, T.; Wylie, Q.; McBride, S.; Lines, M.; Michaud, J.; Baird, S.D.; Chakraborty, P.K.; Holcik, M.
Impaired activity of CCA-adding enzyme TRNT1 impacts OXPHOS complexes and cellular respiration in SIFD patient-derived fibroblasts
Orphanet J. Rare Dis.
11
79
2016
Homo sapiens (Q96Q11)
brenda
Ernst, F.G.; Rickert, C.; Bluschke, A.; Betat, H.; Steinhoff, H.J.; Moerl, M.
Domain movements during CCA-addition: a new function for motif C in the catalytic core of the human tRNA nucleotidyltransferases
RNA Biol.
12
435-446
2015
Homo sapiens (Q96Q11)
brenda
Hennig, O.; Philipp, S.; Bonin, S.; Rollet, K.; Kolberg, T.; Juehling, T.; Betat, H.; Sauter, C.; Moerl, M.
Adaptation of the Romanomermis culicivorax CCA-adding enzyme to miniaturized armless tRNA substrates
Int. j. Mol. Sci.
21
9047
2020
Homo sapiens (Q96Q11), Homo sapiens, Romanomermis culicivorax
brenda
Pawar, K.; Shigematsu, M.; Loher, P.; Honda, S.; Rigoutsos, I.; Kirino, Y.
Exploration of CCA-added RNAs revealed the expression of mitochondrial non-coding RNAs regulated by CCA-adding enzyme
RNA Biol.
16
1817-1825
2019
Homo sapiens
brenda